Correction to: Journal of Bone and Mineral Metabolism https://doi.org/10.1007/s00774-019-01057-1
In the original publication of the article, the last row of Table 1 was published incorrectly as “Serum P1NP (μmol/L), median (IQR)b: Romosozumab, 25 (18, 34); Teriparatide, 25 (20, 33)”. The correct row should be read as “Serum P1NP (μg/L), median (IQR)b: Romosozumab, 25 (18, 34); Teriparatide, 25 (20, 33)”.
In addition, the corresponding footnote for the marker b should read as “bPremenopausal reference range for serum P1NP is 14.9–68.8 µg/L.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Takada, J., Dinavahi, R., Miyauchi, A. et al. Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial. J Bone Miner Metab 38, 605 (2020). https://doi.org/10.1007/s00774-020-01099-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-020-01099-w